ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

August 19, 1983

In Brief: Elion, Schein, Johnson Head Societies; Phillips, Salmon Elected; McIntire, Pistenma to Leave NCI

June 3, 1983

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

November 20, 1998

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

September 26, 1986

Clanton Resigns From NCI.

January 12, 2007

NCI-Approved Clinical Trials

April 29, 2005